Description of event:
3rd International Conference on Vaccines & Vaccination
3rd International Conference on Vaccines & Vaccination during July 29-31, 2013 at Embassy Suites Las Vegas, USA.
Vaccines-2013 is a scientific platform to meet fellow key decision makers all-around the academic institutions, healthcare institutes,
pharmaceutical, biotech, CROs, vaccine developers supply chain, logistics practitioners making the congress a perfect platform to share experience, foster collaborations through the research talks & presentations to put forward many thought provoking strategies in Vaccines & Vaccination, making the Congress a perfect platform to share proficiency.
The first International Conference and Exhibition on Vaccines & Vaccination was held in Philadelphia November 2011 brought together medical specialists, researchers and vaccine developer making it largest and most successful international congregation ever assembled by OMICS Group. and the 2nd International Conference on Vaccines & Vaccination which is going to be held at at Hilton Chicago/Northbrook, USA during August 20-22, 2012 and it is sponsored by Sanofi Pasteur, France.
Now it is the time for 3rd International Conference on Vaccines & Vaccination will feature oral and poster presentations from researchers, health professionals and policy-makers from all over the world on a diverse range of key areas, including:
HIV vaccines, TB vaccines, Malaria vaccines, Hepatitis vaccines,
Influenza vaccines, Dengue Vaccines,
Cancer vaccines, Adjuvant, Vaccine trials and Vaccine safety.
Conference Highlights:
Vaccines and the Basic Immune System
New Approaches for B and
T Cells
Cellular and Molecular-Based Vaccines
Vaccines against Infectious Diseases
Manufacturing, Production, and Development of Vaccines
Regulatory and Ethical Issues of Vaccines and Public Acceptance
Current Issues on
Clinical Evaluation and Field Trials of Vaccines
Modern Technologies in Vaccine Discovery and Development
Age-specific Immune Response to Vaccination
3rd International Conference on Vaccines & Vaccination, having the theme "Recent Innovations and Benchmark Practices in Vaccines & Vaccination."
Vaccines-2013 is comprised of 9 tracks and 58 sessions designed to offer comprehensive sessions that address
current issues in 3rd International Conference on Vaccines & Vaccination.
Vaccines and the Basic Immune System
Track 1-1 Innate and acquired
immunity, attenuated, conjugated, toxoid, and
subunit vaccines
Track 1-2 Vaccine vectors
Track 1-3 Live attenuated, and killed vaccines
Track 1-4 Vaccine characterization,
formulation, and delivery: New challenges and strategies
Track 1-5 Vaccine efficiency & effectiveness
Track 2: New Approaches for B and
T Cells
Track 2-1 Response of B and
T Cells to the pathogens
Track 2-2 Immune responses to vaccines and immunomodulators
Track 2-3 Immunotherapy and chemo immunotherapy
Track 2-4 Nano and micro particles as adjuvants and delivery systems
Track 2-5
Macrophage model systems
Track 2-6 Targeted delivery approaches for vaccines
Track 3: Cellular and Molecular-Based Vaccines
Track 3-1
Peptide vaccines,
DNA vaccines,
cancer vaccines
Track 3-2 Design and development of novel vaccines
Track 3-3
Recombinant DNA vaccine technology
Track 3-4 Polio vaccines,
HIV vaccines
Track 3-5 Development of vaccine for human papilloma
virus
Track 3-6 Carbohydrate / polysaccharide vaccine technology
Track 4: Vaccines against Infectious Diseases
Track 4-1 Vaccines against parasite infections
Track 4-2 Antiviral and antibacterial vaccines
Track 4-3 Biodefence vaccines: The filovirus experience
Track 4-4 Advance in novel pertussis vaccines
Track 4-5 Novel adjuvants
Track 4-6 Plant and
animal based vaccines
Track 4-7
Biomarkers in vaccines
Track 4-8 Rotavirus vaccines
Track 4-9 Pneumococcal vaccines
Track 4-10 Emerging and re-emerging infectious
disease vaccines
Track 4-11 Food safety vaccines, glyco-
conjugate vaccines
Track 5: Manufacturing, Production, and Development of Vaccines
Track 5-1 Techniques for the multi-product vaccine
Track 5-2 Robust and reproducible manufacturing techniques
Track 5-3 QA/QC strategies in vaccine development and production
Track 5-4 Technological improvements for downstream processing of vaccines
Track 5-5 Generation of vaccines using
high-throughput micro bioreactors
Track 5-6 Mechanistic basic prophylactic and
therapeutic vaccines
Track 6: Regulatory and Ethical Issues of Vaccines and Public Acceptance
Track 6-1 Risk assessment and
management of vaccine contamination
Track 6-2 Case studies for
HIV and tropical diseases
Track 6-3 Personalized
medicine development
Track 6-4
Current issues in vaccine communication, safety, and health policies
Track 6-5 Market trend and regulatory aspects of vaccine development and distribution
Track 6-6 Epidemiological studies and scientific assessment of vaccine adverse events
Venue:
Embassy Suites
4315 Swenson Street
Las Vegas, Nevada
United States 89119
Contact us:
Vaccines-2013, OMICS Group Conferences
5716 Corsa Ave, Suite 110, Westlake, Los Angeles, CA 91362-7354, USA